Hyperlipidaemia in practice
نویسندگان
چکیده
منابع مشابه
Hyperlipidaemia: a pilot of a multidisciplinary intervention in general practice
Background and aim: Hyperlipidaemia is a major health concern, and general practitioners have a pivotal role in its management. This pilot study aimed to deliver an efficacious, truly multidisciplinary, hyperlipidaemia management package involving optimal genreal practice medical care together with dietician and nurse educator input. Methods: Subjects identified as having elevated cholesterol l...
متن کاملEzetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia.
BACKGROUND Postprandial hyperlipidaemia is known to be a high-risk factor for atherosclerotic disease because of rapid and lasting accumulations of triglyceride-rich lipoproteins and remnants. The Niemann-Pick C1-Like 1 (NPC1L1) protein acts as an intestinal cholesterol transporter and ezetimibe, which inhibits NPC1L1, has been used in patients with hypercholesterolaemia. We investigated effect...
متن کاملHyperlipidaemia in children.
Hyperlipidaemia in children is most commonly expressed as hypercholesterolaemia. "Normal values" for serum cholesterol, if defined statistically, vary between communities, and levels of cholesterol in childhood above which an increased risk of coronary heart disease in adult life may be expected have not been firmly established. It is suggested that serum cholesterol concentration over 250 mg/d...
متن کاملSecondary hyperlipidaemia.
The secondary hyperlipidaemias occur remarkably frequently, and the underlying cause of high serum lipid levels will often be missed if it is not actively sought. Diagnosis is important because the lipid abnormality responds to treatment of the primary disorder in most cases; notable exceptions to this, however, are the hyperlipidaemias associated with gout and chronic renal failure. The condit...
متن کاملManagement of hyperlipidaemia: guidelines of the British Hyperlipidaemia Association.
There is considerable evidence to suggest that the identification and treatment of dyslipidaemia will reduce the risk of premature CHD, i.e. before the age of 65. Diagnosis of the cause of raised plasma lipid levels will enable appropriate decisions to be taken with regard to management. The cornerstone of treatment is nutritional counselling and attention to other major risk factors for CHD, p...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Vascular Surgery
سال: 1993
ISSN: 0741-5214
DOI: 10.1016/0741-5214(93)90741-4